The Role of Somatic L1 Retrotransposition in Human Cancers

di Scott, Emma C., Devine, Scott E.
Pubblicato in Viruses (2017)

Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab

di Gay, Nathan D., Okada, Craig Y., Chen, Andy I., Scott, Emma C.
Pubblicato in Ther Adv Hematol (2017)

A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer

di Scott, Emma C., Gardner, Eugene J., Masood, Ashiq, Chuang, Nelson T., Vertino, Paula M., Devine, Scott E.
Pubblicato in Genome Res (2016)

How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma

di Cohen, Adam D., Raje, Noopur, Fowler, Jessica A., Mezzi, Khalid, Scott, Emma C, Dhodapkar, Madhav V.
Pubblicato in Clin Cancer Res (2019)

The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology

di Gardner, Eugene J., Lam, Vincent K., Harris, Daniel N., Chuang, Nelson T., Scott, Emma C., Pittard, W. Stephen, Mills, Ryan E., Devine, Scott E.
Pubblicato in Genome Res (2017)

Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma

di Siegel, Matthew B., Liu, Selina Qiuying, Davare, Monika A., Spurgeon, Stephen E., Loriaux, Marc M., Druker, Brian J., Scott, Emma C., Tyner, Jeffrey W.
Pubblicato in Oncotarget (2015)

Partial Correction of the CNS Lysosomal Storage Defect in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis by Neonatal CNS Administration of an Adeno-Associated Virus Serot...

di Sondhi, Dolan, Scott, Emma C., Chen, Alvin, Hackett, Neil R., Wong, Andrew M.S., Kubiak, Agnieszka, Nelvagal, Hemanth R., Pearse, Yewande, Cotman, Susan L., Cooper, Jonathan D., Crystal, Ronald G.
Pubblicazione 2014

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

di Pianko, Matthew J., Funt, Samuel A., Page, David B., Cattry, Deepika, Scott, Emma C., Ansell, Stephen M., Borrello, Ivan M., Gutierrez, Martin, Lendvai, Nikoletta, Hassoun, Hani, Landgren, C. Ola, Lesokhin, Alexander M.
Pubblicato in Leuk Lymphoma (2017)

Differentiation syndrome with ivosidenib and enasidenib treatment in patients with relapsed or refractory IDH-mutated AML: a U.S. Food and Drug Administration systematic analysis

di Norsworthy, Kelly J., Mulkey, Flora, Scott, Emma C., Ward, Ashley F., Przepiorka, Donna, Charlab, Rosane, Dorff, Sarah, Deisseroth, Albert B., Kazandjian, Dickran, Sridhara, Rajeshwari, Beaver, Julia A., Farrell, Ann T., de Claro, R. Angelo, Pazdur, Richard
Pubblicato in Clin Cancer Res (2020)

Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myelo...

di Scott, Emma C., Maziarz, Richard T., Spurgeon, Stephen E., Medvedova, Eva, Gajewski, James, Reasor-Heard, Shara, Park, Byung, Kratz, Anne, Thomas, George V., Loriaux, Marc, Cascio, Michael, Podolak, Jennifer, Gordon, Miranda, Botelho, Jennifer, Stadtmauer, Edward, Amaravadi, Ravi, Vogl, Dan T.
Pubblicato in Haematologica (2017)

Combined autophagy and proteasome inhibition: A phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma

di Vogl, Dan T, Stadtmauer, Edward A, Tan, Kay-See, Heitjan, Daniel F, Davis, Lisa E, Pontiggia, Laura, Rangwala, Reshma, Piao, Shengfu, Chang, Yunyoung C, Scott, Emma C, Paul, Thomas M, Nichols, Charles W, Porter, David L, Kaplan, Janeen, Mallon, Gayle, Bradner, James E, Amaravadi, Ravi K
Pubblicazione 2014

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

di Ansell, Stephen M., Lesokhin, Alexander M., Borrello, Ivan, Halwani, Ahmad, Scott, Emma C., Gutierrez, Martin, Schuster, Stephen J., Millenson, Michael M., Cattry, Deepika, Freeman, Gordon J., Rodig, Scott J., Chapuy, Bjoern, Ligon, Azra H., Zhu, Lili, Grosso, Joseph F., Kim, Su Young, Timmerman, John M., Shipp, Margaret A., Armand, Philippe
Pubblicato in N Engl J Med (2014)

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

di Lesokhin, Alexander M., Ansell, Stephen M., Armand, Philippe, Scott, Emma C., Halwani, Ahmad, Gutierrez, Martin, Millenson, Michael M., Cohen, Adam D., Schuster, Stephen J., Lebovic, Daniel, Dhodapkar, Madhav, Avigan, David, Chapuy, Bjoern, Ligon, Azra H., Freeman, Gordon J., Rodig, Scott J., Cattry, Deepika, Zhu, Lili, Grosso, Joseph F., Bradley Garelik, M. Brigid, Shipp, Margaret A., Borrello, Ivan, Timmerman, John
Pubblicato in J Clin Oncol (2016)

Post-transplant outcomes in high-risk compared to non-high risk multiple myeloma, a CIBMTR analysis

di Scott, Emma C., Hari, Parameswaran, Sharma, Manish, Le-Rademacher, Jennifer, Huang, Jiaxing, Vogl, Dan, Abidi, Muneer, Beitinjaneh, Amer, Fung, Henry, Ganguly, Siddhartha, Hildebrandt, Gerhard, Holmberg, Leona, Kalaycio, Matt, Kumar, Shaji, Kyle, Robert, Lazarus, Hillard, Lee, Cindy, Maziarz, Richard T., Meehan, Kenneth, Mikhael, Joseph, Nishihori, Taiga, Ramanathan, Muthalagu, Usmani, Saad, Tay, Jason, Vesole, David, Wirk, Baldeep, Yared, Jean, Savani, Bipin N., Gasparetto, Cristina, Krishnan, Amrita, Mark, Tomer, Nieto, Yago, D’Souza, Anita
Pubblicato in Biol Blood Marrow Transplant (2016)

Outcomes of Patients with Multiple Myeloma Refractory to CD38-Targeted Monoclonal Antibody Therapy

di Gandhi, Ujjawal H, Cornell, Robert F, Lakshman, Arjun, Gahvari, Zhubin J, McGehee, Elizabeth, Jagosky, Megan H, Gupta, Ridhi, Varnado, William, Fiala, Mark A, Chhabra, Saurabh, Malek, Ehsan, Mansour, Joshua, Paul, Barry, Barnstead, Alyssa, Kodali, Saranya, Neppalli, Amarendra, Liedtke, Michaela, Narayana, Swapna, Godby, Kelly N, Kang, Yubin, Kansagra, Ankit, Umyarova, Elvira, Scott, Emma C, Hari, Parameswaran, Vij, Ravi, Usmani, Saad Z, Callander, Natalie S, Kumar, Shaji K, Costa, Luciano J
Pubblicato in Leukemia (2019)

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

di D'Souza, Anita, Dispenzieri, Angela, Wirk, Baldeep, Zhang, Mei-Jie, Huang, Jiaxing, Gertz, Morie A., Kyle, Robert A., Kumar, Shaji, Comenzo, Raymond L., Peter Gale, Robert, Lazarus, Hillard M., Savani, Bipin N., Cornell, Robert F., Weiss, Brendan M., Vogl, Dan T., Freytes, César O., Scott, Emma C., Landau, Heather J., Moreb, Jan S., Costa, Luciano J., Ramanathan, Muthalagu, Callander, Natalie S., Kamble, Rammurti T., Olsson, Richard F., Ganguly, Siddhartha, Nishihori, Taiga, Kindwall-Keller, Tamila L., Wood, William A., Mark, Tomer M., Hari, Parameswaran
Pubblicato in J Clin Oncol (2015)

Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiati...

di Scott, Emma C., Hari, Parameswaran, Kumar, Sathish, Fraser, Raphael, Davila, Omar, Shah, Nina, Gale, Robert Peter, Diaz, Miguel Angel, Agrawal, Vaibhav, Cornell, Robert F., Ganguly, Siddhartha, Akpek, Gorgun, Freytes, Cesar, Hashmi, Shahrukh, Malek, Ehsan, Kamble, Rammurti T., Lazarus, Hillard, Solh, Melhem, Usmani, Saad Z., Kanate, Abraham S., Saad, Ayman, Chhabra, Saurabh, Gergis, Usama, Cerny, Jan, Kyle, Robert A., Lee, Cindy, Kindwall-Keller, Tamila, Assal, Amer, Hildebrandt, Gerhard C., Holmberg, Leona, Maziarz, Richard T., Nishihori, Taiga, Seo, Sachiko, Kumar, Shaji, Mark, Tomer, D’Souza, Anita
Pubblicato in Biol Blood Marrow Transplant (2018)

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

di Spencer, Andrew, Lentzsch, Suzanne, Weisel, Katja, Avet-Loiseau, Hervé, Mark, Tomer M., Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay K., Quach, Hang, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Scott, Emma C., Chanan-Khan, Asher A., Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Soong, David, Casneuf, Tineke, Chiu, Christopher, Amin, Himal, Qi, Ming, Thiyagarajah, Piruntha, Sasser, A. Kate, Schecter, Jordan M., Mateos, Maria-Victoria
Pubblicato in Haematologica (2018)